- Kroger Health, a unit of Kroger (NYSE:KR), has launched the GLP-1 Complete Support Program for patients using GLP-1 medications for weight management.
- The program offers coordinated access to pharmacists, registered dietitians, clinical services, and personalized nutrition guidance.
- The launch marks an expansion of Kroger’s health and wellness services beyond its traditional grocery retail footprint.
Kroger is using its nationwide footprint and health division to offer more integrated services around weight management, an area drawing heightened consumer and medical attention. The GLP-1 Complete Support Program ties pharmacy, nutrition, and clinical support together, which may matter to customers seeking more structure around GLP-1 use. For investors tracking NYSE:KR, it highlights how the company is trying to use existing in-store capabilities to provide more health focused offerings
As GLP-1 medications remain a focus in weight management treatments, a structured support program could influence how patients choose where to fill prescriptions and seek guidance. For Kroger, the move signals an effort to deepen relationships with health focused shoppers and potentially increase engagement with its pharmacy and nutrition services over time
Stay updated on the most important news stories for Kroger by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Kroger
See which insiders are buying and buying and selling Kroger following this latest news
Advertisement
Quick Assessment
- ✅ Price vs Analyst Target: Kroger trades at US$55.76 versus a consensus target of US$70.64, around 21% below analyst expectations.
- ✅ Simply Wall St Valuation: The stock is flagged as undervalued, trading about 60.7% below one estimate of fair value.
- ❌ Recent Momentum: The share price has declined 2.3% over the past 30 days.
There’s only one way to know the right time to buy, sell or hold Kroger. Head to Simply Wall St’s company report for the latest analysis of Kroger’s Fair Value
Key Considerations
- 📊 The GLP-1 Complete Support Program shows Kroger using its health platform to provide services around a high profile treatment area, which may deepen customer engagement in its stores and pharmacies.
- 📊 Watch uptake of GLP-1 related services, any commentary on health services revenue and how this aligns with Kroger’s current P/E of 32.66 versus the Consumer Retailing industry average of 20.40.
- ⚠️ Kroger has a high level of debt and profit margins of 0.7% that are lower than last year’s 1.7%, so added investment in health offerings needs to be assessed alongside balance sheet and margin trends.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Kroger analysis. Alternatively, you can check out the community page for Kroger to see how other investors believe this latest news will impact the company’s narrative
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it
Discover if Kroger might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition
Access Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
About NYSE:KR
Kroger
Operates as a food and drug retailer in the United States
See The Free Research Report
Established dividend payer with slight risk
See The Free Research Report
Similar Companies
NasdaqGS:CART
Maplebear
Albertsons Companies
Market Insights
Why 2026’s worst-looking sector might be its most misreadMitchell Lawler
A brand’s strength doesn’t always lastRichard Bowman
What makes a lasting brand?Andrew Legget
Advertisement
Weekly Picks
LO
Lou_Baseneseon Optimi Health·about 1 month ago
The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist
Fair Value:US$1156.8% undervalued
34followersusers have followed this narrative
·2commentsusers have commented on this narrative
·6likesusers have liked this narrative
WE
WealthAPon Novo Nordisk·7 months ago
Novo Nordisk (NVO): Is the “Easy Growth” Story Over?
Fair Value:DKK 407.7721.5% undervalued
56followersusers have followed this narrative
·0commentsusers have commented on this narrative
·7likesusers have liked this narrative
VA
ValueInvestingSubstackon Zoetis·about 2 months ago
Zoetis down -50% over the past year
Fair Value:US$92.9219.7% undervalued
20followersusers have followed this narrative
·0commentsusers have commented on this narrative
·8likesusers have liked this narrative
CE
CentryResearchon Centrus Energy·7 days ago
Centrus Energy: The Next Nuclear Bottleneck Isn’t Reactors. It’s Fuel
Fair Value:US$19010.1% undervalued
16followersusers have followed this narrative
·0commentsusers have commented on this narrative
·8likesusers have liked this narrative
RecentlyUpdated Narratives
TA
Taloson Zevra Therapeutics·about 4 hours ago
The “Rare Disease Monopoly” – Commercial Execution Play
Fair Value:US$12.053.9% overvalued
3followersusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
FU
FundamentalFlowon Vistra·about 6 hours ago
US Energy Giant: PowerHouse Of The Future Of AI
Fair Value:US$299.9843.7% undervalued
2followersusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
ES
Estebanon Mastercard·about 21 hours ago
Capital-light, high-return payment network that is successfully expanding into high-margin security and data services faster than its peers
Fair Value:US$395.534.1% overvalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
Popular Narratives
BE
benjamin_lvieqon PayPal Holdings·9 days ago
PayPal: PayPal Doesn’t Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback
Fair Value:US$6513.8% undervalued
70followersusers have followed this narrative
·2commentsusers have commented on this narrative
·11likesusers have liked this narrative
CU
CubanEroson Microsoft·20 days ago
A wonderful business at reasonable price
Fair Value:US$419.919.1% undervalued
70followersusers have followed this narrative
·0commentsusers have commented on this narrative
·5likesusers have liked this narrative
TR
tripledubon Alphabet·about 2 months ago
Warren Buffett Just Bet $10 Billion on Google. The Catch? You May Already Be Too Late
Fair Value:US$23038.1% overvalued
92followersusers have followed this narrative
·1commentusers have commented on this narrative
·18likesusers have liked this narrative
